Shopping Cart
Remove All
Your shopping cart is currently empty
XL44, as an hRpn13 binder, triggers hRpn13-dependent apoptosis and limits cell viability via a PCLAF-dependent mechanism. It causes ubiquitin-dependent degradation of hRpn13 Pru and ubiquitin-independent degradation of specific KEN box-containing proteins [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | XL44, as an hRpn13 binder, triggers hRpn13-dependent apoptosis and limits cell viability via a PCLAF-dependent mechanism. It causes ubiquitin-dependent degradation of hRpn13 Pru and ubiquitin-independent degradation of specific KEN box-containing proteins [1]. |
| In vitro | XL44, when applied at a concentration of 20 μM to RPMI 8226 cell lysates over a period of 4-24 hours, triggers apoptosis through an hRpn13-dependent mechanism and diminishes hRpn13Pru levels [1]. Western Blot Analysis confirms these findings [1]. |
| Molecular Weight | 388.39 |
| Formula | C23H17FN2O3 |
| Cas No. | 2637949-91-6 |
| Smiles | C(=C1C=2C(NC1=O)=CC=C(F)C2)C3=CC(NC(=O)C4=CC=C(OC)C=C4)=CC=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.